Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · IEX Real-Time Price · USD
1.130
+0.170 (17.71%)
At close: May 2, 2024, 4:00 PM
1.060
-0.070 (-6.19%)
After-hours: May 2, 2024, 7:59 PM EDT
Aptevo Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
40
Market Cap
760.98K USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 3.11M | -9.18M | -74.67% |
Dec 31, 2021 | 12.29M | 7.98M | 185.26% |
Dec 31, 2020 | 4.31M | - | - |
Dec 31, 2019 | 0 | - | - |
Dec 31, 2018 | 23.07M | 8.41M | 57.37% |
Dec 31, 2017 | 14.66M | 4.67M | 46.80% |
Dec 31, 2016 | 9.99M | -23.62M | -70.28% |
Dec 31, 2015 | 33.60M | -12.03M | -26.36% |
Dec 31, 2014 | 45.63M | 45.46M | 26,741.76% |
Dec 31, 2013 | 170.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAPVO News
- 17 days ago - Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering - Accesswire
- 21 days ago - Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering - Accesswire
- 22 days ago - Aptevo Therapeutics Provides Pipeline Update - Accesswire
- 6 weeks ago - Aptevo Participating in The Springtime Partnering Event, a Bio-Europe Conference - Accesswire
- 2 months ago - Aptevo Therapeutics Reports 2023 Financial Results and Provides a Business Update - Accesswire
- 2 months ago - Aptevo Therapeutics Announces 1-for 44 Reverse Stock Split As Part of Nasdaq Compliance Plan - Accesswire
- 6 months ago - Aptevo Therapeutics Reports 3Q23 Financial Results and Provides a Business Update - Accesswire
- 6 months ago - Aptevo to Present at Bio-Europe Conference - Accesswire